Tomorrow’s quantitation: increased robustness for quantitation of immunosuppressant drugs in blood with the TSQ Fortis MS for clinical research

contributed by Thermo Fisher Scientific | 11/29/2018

Development of a robust, reliable, and reproducible workflow solution for the analysis and quantitation of immunosuppressant drugs in blood for clinical research using triple quadrupole mass spectrometry coupled with ultra-high performing liquid chromatography.

Email*

Choose a password*

I have read and understand the Privacy Notice *

Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

I want to stay up to date with the Retina field I want to stay up to date with the Infectious Diseases field I want to stay up to date with the Pathologist Educator field

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.